FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113854818> ?p ?o ?g. }

• W2113854818 endingPage "1247" @default.
• W2113854818 startingPage "1240" @default.
• W2113854818 abstract "Objectives We studied the prognostic value of plasma N‐terminal pro‐brain natriuretic peptide (NT‐proBNP)‐ratio, which is independent of individual cutoff levels, in predicting mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background : Elevated levels of natriuretic peptides are associated with adverse outcomes across a wide spectrum of cardiovascular diseases. However, cutoff values differ according to age, gender, and body weight. Methods : 244 TAVR patients with preprocedural NT‐proBNP levels were analyzed, and the predictive value of NT‐proBNP‐ratio (measured NT‐proBNP/maximal normal NT‐proBNP values specific for age and gender) on all‐cause‐mortality was assessed in a multivariate model. Results : Median NT‐proBNP‐ratio was 4.2 [IQR 1.8–9.7]. All‐cause mortality at 30 days was 3.4% in patients with less than median NT‐proBNP‐ratio, and 14.0% in patients with more than median NT‐proBNP‐ratio ( P = 0.02). All‐cause mortality at 1 year was 8.5% in patients with less than median NT‐proBNP‐ratio, and 32.1% in those with more than median NT‐proBNP‐ratio ( P = 0.001). Cumulative survival declined with increasing quartiles of NT‐proBNP‐ratio (log rank P = 0.001). All patients with a NT‐proBNP‐ratio below 1.5 survived at 1‐year follow‐up. In ROC analysis, NT‐proBNP‐ratio significantly predicted 30‐day (AUC = 0.72; P = 0.002) and 1‐year all‐cause mortality (AUC = 0.72; P < 0.001). By multivariate Cox regression analysis, NT‐proBNP‐ratio, chronic obstructive pulmonary disease, and serum creatinine were the only independent predictors of all‐cause mortality. Conclusions : Elevated NT‐proBNP‐ratio was associated with increased short‐ and long‐term mortality after TAVR, and independently predicted all‐cause mortality. NT‐proBNP‐ratio should be considered in the risk stratification of patients undergoing TAVR. © 2015 Wiley Periodicals, Inc." @default.
• W2113854818 created "2016-06-24" @default.
• W2113854818 creator A5003114438 @default.
• W2113854818 creator A5023950438 @default.
• W2113854818 creator A5028939195 @default.
• W2113854818 creator A5034137141 @default.
• W2113854818 creator A5045293936 @default.
• W2113854818 creator A5045354508 @default.
• W2113854818 creator A5060241889 @default.
• W2113854818 creator A5062985967 @default.
• W2113854818 creator A5070389994 @default.
• W2113854818 creator A5086702927 @default.
• W2113854818 date "2015-01-19" @default.
• W2113854818 modified "2023-09-25" @default.
• W2113854818 title "N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement" @default.
• W2113854818 cites W1970667076 @default.
• W2113854818 cites W1972592020 @default.
• W2113854818 cites W1984344423 @default.
• W2113854818 cites W1997859168 @default.
• W2113854818 cites W2025576182 @default.
• W2113854818 cites W2032848846 @default.
• W2113854818 cites W2037507673 @default.
• W2113854818 cites W2037639604 @default.
• W2113854818 cites W2037646226 @default.
• W2113854818 cites W2042665434 @default.
• W2113854818 cites W2056904027 @default.
• W2113854818 cites W2061724830 @default.
• W2113854818 cites W2082009879 @default.
• W2113854818 cites W2084377033 @default.
• W2113854818 cites W2087803072 @default.
• W2113854818 cites W2102051152 @default.
• W2113854818 cites W2115859167 @default.
• W2113854818 cites W2116507628 @default.
• W2113854818 cites W2126178196 @default.
• W2113854818 cites W2132585880 @default.
• W2113854818 cites W2134463370 @default.
• W2113854818 cites W2140732936 @default.
• W2113854818 cites W2143099321 @default.
• W2113854818 cites W2151736360 @default.
• W2113854818 cites W2153985424 @default.
• W2113854818 cites W2156656750 @default.
• W2113854818 cites W2166973706 @default.
• W2113854818 cites W4250082639 @default.
• W2113854818 cites W52216723 @default.
• W2113854818 cites W56250199 @default.
• W2113854818 doi "https://doi.org/10.1002/ccd.25788" @default.
• W2113854818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25511571" @default.
• W2113854818 hasPublicationYear "2015" @default.
• W2113854818 type Work @default.
• W2113854818 sameAs 2113854818 @default.
• W2113854818 citedByCount "23" @default.
• W2113854818 countsByYear W21138548182015 @default.
• W2113854818 countsByYear W21138548182016 @default.
• W2113854818 countsByYear W21138548182018 @default.
• W2113854818 countsByYear W21138548182019 @default.
• W2113854818 countsByYear W21138548182020 @default.
• W2113854818 countsByYear W21138548182021 @default.
• W2113854818 countsByYear W21138548182022 @default.
• W2113854818 countsByYear W21138548182023 @default.
• W2113854818 crossrefType "journal-article" @default.
• W2113854818 hasAuthorship W2113854818A5003114438 @default.
• W2113854818 hasAuthorship W2113854818A5023950438 @default.
• W2113854818 hasAuthorship W2113854818A5028939195 @default.
• W2113854818 hasAuthorship W2113854818A5034137141 @default.
• W2113854818 hasAuthorship W2113854818A5045293936 @default.
• W2113854818 hasAuthorship W2113854818A5045354508 @default.
• W2113854818 hasAuthorship W2113854818A5060241889 @default.
• W2113854818 hasAuthorship W2113854818A5062985967 @default.
• W2113854818 hasAuthorship W2113854818A5070389994 @default.
• W2113854818 hasAuthorship W2113854818A5086702927 @default.
• W2113854818 hasConcept C121332964 @default.
• W2113854818 hasConcept C126322002 @default.
• W2113854818 hasConcept C144494922 @default.
• W2113854818 hasConcept C164705383 @default.
• W2113854818 hasConcept C207103383 @default.
• W2113854818 hasConcept C2775915353 @default.
• W2113854818 hasConcept C2778198053 @default.
• W2113854818 hasConcept C2778217198 @default.
• W2113854818 hasConcept C38180746 @default.
• W2113854818 hasConcept C44249647 @default.
• W2113854818 hasConcept C50382708 @default.
• W2113854818 hasConcept C58471807 @default.
• W2113854818 hasConcept C62520636 @default.
• W2113854818 hasConcept C68443243 @default.
• W2113854818 hasConcept C71924100 @default.
• W2113854818 hasConceptScore W2113854818C121332964 @default.
• W2113854818 hasConceptScore W2113854818C126322002 @default.
• W2113854818 hasConceptScore W2113854818C144494922 @default.
• W2113854818 hasConceptScore W2113854818C164705383 @default.
• W2113854818 hasConceptScore W2113854818C207103383 @default.
• W2113854818 hasConceptScore W2113854818C2775915353 @default.
• W2113854818 hasConceptScore W2113854818C2778198053 @default.
• W2113854818 hasConceptScore W2113854818C2778217198 @default.
• W2113854818 hasConceptScore W2113854818C38180746 @default.
• W2113854818 hasConceptScore W2113854818C44249647 @default.
• W2113854818 hasConceptScore W2113854818C50382708 @default.
• W2113854818 hasConceptScore W2113854818C58471807 @default.
• W2113854818 hasConceptScore W2113854818C62520636 @default.

• next